Advertisements


We are Sorry, This Page doesn't Exist


Pfizer and Eli Lilly Win in Late-Stage Osteoarthitis Study

Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in patients with osteoarthritis pain......»»

Category: blogSource: 247wallst2 hr. 30 min. ago

Teladoc Is the Future of Healthcare

InvestorPlace - Stock Market News, Stock Advice & Trading Tips When betting on an industry of the future, it’s typically a good idea to invest in the leader of that space. That’s the strategy I̵.....»»

Category: topSource: investorplaceJul 17th, 2018

Firms That Mention Trade Secrets In SEC Filings Increase Risk Of Being Cyber-Attacked, Study Suggests

Firms that refer in annual reports to their trade secrets + markedly increase risk of cyber-attacks, study suggests “.....»»

Category: blogSource: valuewalkJul 16th, 2018

Planemakers to kickstart Farnborough jetliner order battle

Aerospace firms Airbus and Boeing will kickstart a contest for tens of billions of dollars of orders at the Farnborough Airshow on Monday, ensuring fireworks start early as they seek to bolster their already bulging order books......»»

Category: topSource: reutersJul 15th, 2018

Bankrate Study: 10 Worst States to Retire List for 2018

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bankrate has delivered once again with its 2018 list of the best and worst states to retire, a selection that looks at a multitude of factors when deciding the best and.....»»

Category: topSource: investorplaceJul 12th, 2018

Bankrate Study: 10 Best States to Retire List for 2018

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bankrate .....»»

Category: topSource: investorplaceJul 12th, 2018

Mid-Afternoon Market Update: Dow Up Over 200 Points; Zogenix Shares Gain On Positive Phase 3 Data In Dravet Syndrome Study

Toward the end of trading Thursday, the Dow traded up 0.88 percent to 24,918.80 while the NASDAQ climbed 1.19 percent to 7,808.43. The S&P also rose, gaining 0.81 percent to 2,796.34. read more.....»»

Category: blogSource: benzingaJul 12th, 2018

Edward Jones, Stifel lead in adviser satisfaction

Two St. Louis financial firms ranked first and third in the J.D. Power 2018 U.S. Financial Advisor Satisfaction Study. For the 10th time, Edward Jones topped the ranking of employee advisers at 909 on a scale of 1,000. Another St. Louis-based firm,.....»»

Category: topSource: bizjournalsJul 11th, 2018

Ex-employees at two Cambridge biotechs convicted in insider trading case

Two former employees of Cambridge biotech firms Akebia Therapeutics and Merrimack Pharmaceuticals were convicted of insider trading on Tuesday by a federal jury in Boston. Schultz “Jason” Chan, 54, of Newton was convicted of one count of consp.....»»

Category: topSource: bizjournalsJul 10th, 2018

Mid-Afternoon Market Update: OncoCyte Surges Following Positive DetermaVu Study Results; IsoRay Shares Drop

Toward the end of trading Tuesday, the Dow traded up 0.57 percent to 24,918.21 while the NASDAQ climbed 0.03 percent to 7,758.14. The S&P also rose, gaining 0.32 percent to 2,793.11. read more.....»»

Category: blogSource: benzingaJul 10th, 2018

FINRA Wants to Know All About Member Firms" Crypto Activities

The U.S. financial self-regulatory body is asking member firms to submit every detail of their existing or future activities in cryptocurrency......»»

Category: forexSource: coindeskJul 9th, 2018

Biotech ETFs Surge on Biogen"s Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment. Biogen Inc. BIIB was a star performer in Friday’s trading session, as the stock rallied as much as 23.1% but closed a l.....»»

Category: worldSource: nytJul 9th, 2018

Businesses have finally run out of patience with the UK government"s handling of Brexit

REUTERS/Henry Nicholls Major manufactures employing over 70,000 people in the UK have put pressure on the government in recent weeks over Brexit. Businesses want more clarity over Britain's future trading relationship with the E.....»»

Category: topSource: businessinsiderJul 7th, 2018

Business have finally run out of patience with the UK government"s handling of Brexit

REUTERS/Henry Nicholls Major manufactures employing over 70,000 people in the UK have put pressure on the government in recent weeks over Brexit. Businesses want more clarity over Britain's future trading relationship with the E.....»»

Category: topSource: businessinsiderJul 7th, 2018

Adam Feuerstein Cautious On Biogen Following Alzheimer"s Study

On Friday's PreMarket Prep trading show, STAT News senior writer Adam Feuerstein weighed in on the results from Biogen Inc (NASDAQ: BIIB) and Eisai's read more.....»»

Category: blogSource: benzingaJul 6th, 2018

Aviation giant Airbus doubles down on Brexit warning to UK

Aviation giant Airbus has underscored its threat to leave Britain if the country exits the European Union without an agreement on future trading relations......»»

Category: topSource: foxnewsJul 6th, 2018

The Long Crisis Looms: UK Govt Economic Advisor Warns "Growth Is Ending"

Authored by Nafeez Ahmed via Insurge Intelligence (@Medium.com), Study charts the protracted collapse of industrial economic growth and why prosperity must be built on a new economic .....»»

Category: blogSource: zerohedgeJul 6th, 2018

Mid-Afternoon Market Update: Dow Up 100 Points; Zynerba Shares Fall After ZYN001 Study Fails To Meet Top-Line Results

Toward the end of trading Thursday, the Dow traded up 0.42 percent to 24,275.15 while the NASDAQ climbed 0.74 percent to 7,558.15. The S&P also rose, gaining 0.54 percent to 2,727.95. read more.....»»

Category: blogSource: benzingaJul 5th, 2018

EU"s Nativist Swing Casts Shadow Over Current Structure"s Future

In Europe’s long struggle between the political establishment and its enemies, the momentum this year is shifting toward nativists, deepening doubts about the continent’s multilateral order and divisions about how to respond......»»

Category: topSource: wsjJul 5th, 2018

LYV Stock Shows Promise, But it’s a No-Go at These Levels

InvestorPlace - Stock Market News, Stock Advice & Trading Tips LYV is simply too expensive to be a buy right now. Live Nation Entertainment's future prospects look.....»»

Category: topSource: investorplaceJul 5th, 2018